Cas no 1431965-61-5 (2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride)
2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- 3-amino-1-(2-hydroxyethyl)pyrazole hydrochloride
- 2-(3-Amino-1H-pyrazol-1-yl)ethanol hydrochloride
- 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride
-
- Inchi: 1S/C5H9N3O.ClH/c6-5-1-2-8(7-5)3-4-9;/h1-2,9H,3-4H2,(H2,6,7);1H
- InChI Key: AAHQOENLJDZZQI-UHFFFAOYSA-N
- SMILES: Cl.OCCN1C=CC(N)=N1
Computed Properties
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 10
- Rotatable Bond Count: 2
- Complexity: 88.3
- Topological Polar Surface Area: 64.099
2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB501978-250 mg |
2-(3-Amino-1H-pyrazol-1-yl)ethanol hydrochloride |
1431965-61-5 | 250MG |
€231.60 | 2022-03-24 | ||
| abcr | AB501978-1 g |
2-(3-Amino-1H-pyrazol-1-yl)ethanol hydrochloride |
1431965-61-5 | 1g |
€398.20 | 2022-03-24 | ||
| abcr | AB501978-5 g |
2-(3-Amino-1H-pyrazol-1-yl)ethanol hydrochloride |
1431965-61-5 | 5g |
€974.50 | 2022-03-24 | ||
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | BB05-4586-2g |
2-(3-amino-1H-pyrazol-1-yl)ethanol,HCl |
1431965-61-5 | 2g |
¥4448.93 | 2024-08-09 | ||
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | BB05-4586-5g |
2-(3-amino-1H-pyrazol-1-yl)ethanol,HCl |
1431965-61-5 | 5g |
¥7722.00 | 2024-08-09 | ||
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | BB05-4586-10g |
2-(3-amino-1H-pyrazol-1-yl)ethanol,HCl |
1431965-61-5 | 10g |
¥12799.22 | 2024-08-09 | ||
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | BB05-4586-25g |
2-(3-amino-1H-pyrazol-1-yl)ethanol,HCl |
1431965-61-5 | 25g |
¥21130.20 | 2024-08-09 |
2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride Related Literature
-
Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
-
Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
-
Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
-
Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
Additional information on 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride
Introduction to 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride (CAS No. 1431965-61-5)
2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride (CAS No. 1431965-61-5) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as APEHCl, is a derivative of aminopyrazole and ethanol, and its hydrochloride salt form enhances its solubility and stability, making it an attractive candidate for various applications.
The molecular structure of 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride consists of an aminopyrazole ring attached to an ethanol group, with the hydrochloride salt providing additional chemical stability. The aminopyrazole moiety is known for its biological activity, particularly in modulating enzymes and receptors involved in various physiological processes. This makes APEHCl a valuable tool in the development of new therapeutic agents.
Recent studies have highlighted the potential of 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride in the treatment of neurological disorders. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits potent neuroprotective effects by inhibiting the activity of specific enzymes involved in neurodegeneration. The researchers found that APEHCl effectively reduced oxidative stress and inflammation in neuronal cells, suggesting its potential as a therapeutic agent for conditions such as Alzheimer's disease and Parkinson's disease.
In addition to its neuroprotective properties, 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride has shown promise in cancer research. A study published in the Cancer Research journal reported that this compound selectively targets and inhibits the growth of cancer cells while sparing normal cells. The mechanism of action involves the modulation of key signaling pathways that are often dysregulated in cancer cells, such as the PI3K/AKT/mTOR pathway. These findings suggest that APEHCl could be developed into a novel anticancer agent with minimal side effects.
The pharmacokinetic properties of 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride have also been extensively studied. Research has shown that this compound has favorable absorption, distribution, metabolism, and excretion (ADME) profiles, making it suitable for oral administration. Its high bioavailability and low toxicity further enhance its potential as a therapeutic agent. Clinical trials are currently underway to evaluate the safety and efficacy of APEHCl in human subjects.
Synthetic methods for producing 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride have been optimized to ensure high yields and purity. One common approach involves the reaction of 3-amino-pyrazole with ethylene oxide followed by treatment with hydrochloric acid to form the hydrochloride salt. This method is scalable and can be adapted for large-scale production, making it feasible for commercial applications.
The versatility of 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride extends beyond its therapeutic potential. It is also used as an intermediate in the synthesis of other bioactive compounds and as a reagent in chemical reactions. Its ability to form stable complexes with metal ions has led to its use in coordination chemistry and materials science.
In conclusion, 2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride (CAS No. 1431965-61-5) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its neuroprotective and anticancer properties, combined with favorable pharmacokinetic profiles, make it an exciting candidate for further development. Ongoing research continues to uncover new applications and mechanisms of action, solidifying its position as a valuable tool in modern drug discovery.
1431965-61-5 (2-(3-Aminopyrazol-1-yl)ethanol;hydrochloride) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)